Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic ServiceDineke Westra, Nicol C. Voermans, Meyke Schouten et al.|Journal of Neuromuscular Diseases|2019Cited by 50
Domain mapping of disease mutations supports genetic testing of specific <i>SORL1</i> variants in familial Alzheimer’s DiseaseHenne Holstege, Afina W. Lemstra, Gary W. Beecham et al.|medRxiv|2023Cited by 11
Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory ClinicSven J. van der Lee, Henne Holstege, Marc Hulsman et al.|Neurology|2025Cited by 8
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer’s diseaseOlav M. Andersen, M Lathrop, Matthijs W. J. de Waal et al.|Molecular Neurodegeneration|2025Cited by 2
Data driven criteria for genetic testing result in an efficient selection of patients with genetic dementia in a clinical settingSven J Van Der Lee, Henne Holstege, Marc Hulsman et al.|Alzheimer s & Dementia|2023Cited by 0